220 related articles for article (PubMed ID: 20561327)
1. Willingness to pay for lung cancer treatment.
Lang HC
Value Health; 2010; 13(6):743-9. PubMed ID: 20561327
[TBL] [Abstract][Full Text] [Related]
2. Estimating Willingness to Pay for an Improved Service Delivery to Patients Referring Namazi Hospital Chemical Therapy Ward in Iran Using Contingent Valuation.
Kavosi Z; Jafari A; Keshtkaran V; Pourahmadi E
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1817-1823. PubMed ID: 30049193
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
Tang CH; Liu JT; Chang CW; Chang WY
Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
[TBL] [Abstract][Full Text] [Related]
4. Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan.
Chen YT; Ying YH; Chang K; Hsieh YH
Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26938547
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities, quality of life and patients' willingness to pay for a cure for type 2 diabetes in Taiwan.
Chang K
Public Health; 2010 May; 124(5):284-94. PubMed ID: 20546817
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Willingness to Pay for a Contributory National Health Insurance Scheme in Saudi Arabia: A Cross-sectional Stated Preference Approach.
Al-Hanawi MK; Vaidya K; Alsharqi O; Onwujekwe O
Appl Health Econ Health Policy; 2018 Apr; 16(2):259-271. PubMed ID: 29307076
[TBL] [Abstract][Full Text] [Related]
7. Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer.
Miller PJ; Balu S; Buchner D; Walker MS; Stepanski EJ; Schwartzberg LS
J Med Econ; 2013 Oct; 16(10):1179-89. PubMed ID: 23919632
[TBL] [Abstract][Full Text] [Related]
8. Willingness to pay for social health insurance among informal sector workers in Wuhan, China: a contingent valuation study.
Bärnighausen T; Liu Y; Zhang X; Sauerborn R
BMC Health Serv Res; 2007 Jul; 7():114. PubMed ID: 17659084
[TBL] [Abstract][Full Text] [Related]
9. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
10. Willingness to pay for National Health Insurance Fund among public servants in Juba City, South Sudan: a contingent evaluation.
Basaza R; Alier PK; Kirabira P; Ogubi D; Lako RLL
Int J Equity Health; 2017 Aug; 16(1):158. PubMed ID: 28854972
[TBL] [Abstract][Full Text] [Related]
11. Analysis of willingness to pay for implantable cardioverter-defibrillator therapy.
Nowakowska D; Guertin JR; Liu A; Abrahamowicz M; Lelorier J; Lespérance F; Brophy JM; Rinfret S
Am J Cardiol; 2011 Feb; 107(3):423-7. PubMed ID: 21257009
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for weight-control treatment.
Liu JT; Tsou MW; Hammitt JK
Health Policy; 2009 Jul; 91(2):211-8. PubMed ID: 19167128
[TBL] [Abstract][Full Text] [Related]
13. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
Pinto-Prades JL; Farreras V; de Bobadilla JF
Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
15. Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.
Li C; Zeliadt SB; Hall IJ; Smith JL; Ekwueme DU; Moinpour CM; Penson DF; Thompson IM; Keane TE; Ramsey SD
Value Health; 2012; 15(5):716-23. PubMed ID: 22867781
[TBL] [Abstract][Full Text] [Related]
16. Never will I give advice till you please to ask me thrice: Estimating willingness to pay for health insurance using 3 different methods with evidence from Iran.
Moeeni M; Nosratnejad S
Int J Health Plann Manage; 2019 Jan; 34(1):e594-e601. PubMed ID: 30265410
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay for low-lung-cancer-risk cigarettes in Taiwan.
Jan MS; Fu TT; Huang CL
Health Econ; 2005 Jan; 14(1):55-67. PubMed ID: 15386675
[TBL] [Abstract][Full Text] [Related]
18. [Acceptance and understandability of various methods of health valuations for the chronically ill: willingness to pay, visual analogue scale and rating scale].
Meder M; Farin E
Gesundheitswesen; 2009 Nov; 71(11):e62-71. PubMed ID: 20094981
[TBL] [Abstract][Full Text] [Related]
19. Willingness-to-pay for community-based insurance in Burkina Faso.
Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
[TBL] [Abstract][Full Text] [Related]
20. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.
Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N
Value Health; 2008; 11(4):575-88. PubMed ID: 18179657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
